phase 1_completion
saveDaewoong Therapeutics Inc — semaglutide (Phase I Trial Completion)
community read0 votes
Therapy area: Metabolic Disorders. Indication: Diabetes, Obesity, Overweight, Type 2 Diabetes
Therapy area: Metabolic Disorders. Indication: Diabetes, Obesity, Overweight, Type 2 Diabetes